相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Pharmacodynamics of the Antibacterial Effect of and Emergence of Resistance to Doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an In Vitro Pharmacokinetic Model
Karen E. Bowker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study
Pattarachai Kiratisin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
Marie Kempf et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Acinetobacter Infection - an Emerging Threat to Human Health
Paolo Visca et al.
IUBMB LIFE (2011)
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy
Silvia D'Arezzo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii
Glenn A. Pankuch et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates
Pattarachai Kiratisin et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Global spread of carbapenem-resistant Acinetobacter baumannii
Paul G. Higgins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy)
S. D'Arezzo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
In vitro activity of doripenem against Acinetobacter baumannii clinical isolates
Sara Marti et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies
J. M. Entenza et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
Luigi Principe et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2009)
Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group
Michele Iacono et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
N. Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
A review of tigecycline - the first glycylcycline
Lance R. Peterson
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii
Alessandro Capone et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Rapid development of Acinetobacter baumannii resistance to tigecycline
Gail E. Reid et al.
PHARMACOTHERAPY (2007)
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumanni
Marc H. Scheetz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
Shiri Navon-Venezia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
New uses for older antibiotics: Nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited
Burke A. Cunha
MEDICAL CLINICS OF NORTH AMERICA (2006)
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis
PJ Petersen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The pharmacokinetic and pharmacodynamic profile of tigecycline
AK Meagher et al.
CLINICAL INFECTIOUS DISEASES (2005)
Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic
A Nemec et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2004)